CD8A and classic Hodgkin lymphoma: However, reduced ex‐vivo HLA‐A*02– global (i.e. mediated through all co‐expressed HLA‐alleles) LMP1/LMP2A‐specific effector CD8+ T cell responses were observed only in EBV+cHL patients.